PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2005. Start Trial.
Date Value
November 16, 2026 5.110
November 13, 2026 5.055
November 12, 2026 5.072
November 11, 2026 5.078
November 10, 2026 5.121
November 09, 2026 5.141
November 06, 2026 4.978
November 05, 2026 4.984
November 04, 2026 5.109
November 03, 2026 4.962
November 02, 2026 5.086
October 30, 2026 5.137
October 29, 2026 5.095
October 28, 2026 5.049
October 27, 2026 5.061
October 26, 2026 5.029
October 23, 2026 5.128
October 22, 2026 4.998
October 21, 2026 4.956
October 20, 2026 4.956
October 19, 2026 4.790
October 16, 2026 4.790
October 15, 2026 4.760
October 14, 2026 4.669
October 13, 2026 4.508
Date Value
October 12, 2026 4.536
October 09, 2026 4.535
October 08, 2026 4.474
October 07, 2026 4.533
October 06, 2026 4.406
October 05, 2026 4.402
October 02, 2026 4.380
October 01, 2026 4.389
September 30, 2026 4.350
September 29, 2026 4.380
September 28, 2026 4.474
September 25, 2026 4.565
September 24, 2026 4.594
September 23, 2026 4.616
September 22, 2026 4.666
September 21, 2026 4.636
September 18, 2026 4.540
September 17, 2026 4.580
September 16, 2026 4.624
September 15, 2026 4.606
September 14, 2026 4.594
September 11, 2026 4.422
September 10, 2026 4.459
September 09, 2026 4.475
September 08, 2026 4.533

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Novartis AG 5.506
AstraZeneca PLC 9.408
GSK Plc 2.230
Johnson & Johnson 6.861
Eli Lilly & Co. 14.79

PS Ratio Related Metrics